Trial intelligence / Profile preview

Convalescent Plasma Therapy in Severe COVID-19

NCT04425915Phase 3Completed

Sponsor
Institute of Liver and Biliary Sciences
Start
Jun 2020
Primary completion
Dec 2020
Modality
Biologic
Countries
1
01

Overview

A Phase 3 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Institute of Liver and Biliary Sciences. Started Jun 2020; status: completed.

02

Drugs

convalescent plasma (Heinrich-Heine University, Duesseldorf)
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04425915.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04425915.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call